A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 4,188,524 shares of GILD stock, worth $388 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
4,188,524
Previous 5,057,598 17.18%
Holding current value
$388 Million
Previous $347 Million 1.18%
% of portfolio
0.56%
Previous 0.61%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$66.59 - $83.99 $57.9 Million - $73 Million
-869,074 Reduced 17.18%
4,188,524 $351 Million
Q2 2024

Aug 09, 2024

BUY
$63.15 - $72.88 $46.7 Million - $53.9 Million
739,948 Added 17.14%
5,057,598 $347 Million
Q1 2024

May 13, 2024

SELL
$71.58 - $87.29 $90.1 Million - $110 Million
-1,258,200 Reduced 22.57%
4,317,650 $316 Million
Q4 2023

Feb 13, 2024

SELL
$73.27 - $83.09 $63.6 Million - $72.1 Million
-867,534 Reduced 13.46%
5,575,850 $452 Million
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $98.9 Million - $108 Million
-1,338,032 Reduced 17.2%
6,443,384 $483 Million
Q2 2023

Aug 11, 2023

SELL
$76.01 - $86.7 $213 Million - $243 Million
-2,802,800 Reduced 26.48%
7,781,416 $600 Million
Q1 2023

May 12, 2023

BUY
$77.31 - $88.08 $107 Million - $122 Million
1,381,648 Added 15.01%
10,584,216 $878 Million
Q4 2022

Feb 13, 2023

SELL
$62.32 - $89.47 $51.1 Million - $73.4 Million
-820,000 Reduced 8.18%
9,202,568 $790 Million
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $202 Million - $230 Million
-3,387,048 Reduced 25.26%
10,022,568 $618 Million
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $120 Million - $135 Million
-2,082,500 Reduced 13.44%
13,409,616 $829 Million
Q1 2022

May 13, 2022

BUY
$57.92 - $72.58 $371 Million - $465 Million
6,410,047 Added 70.58%
15,492,116 $921 Million
Q4 2021

Feb 11, 2022

BUY
$64.88 - $73.64 $232 Million - $264 Million
3,581,114 Added 65.1%
9,082,069 $659 Million
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $30.7 Million - $33.1 Million
453,600 Added 8.99%
5,500,955 $384 Million
Q2 2021

Aug 13, 2021

SELL
$63.47 - $69.35 $96.1 Million - $105 Million
-1,513,648 Reduced 23.07%
5,047,355 $348 Million
Q1 2021

May 13, 2021

BUY
$60.0 - $68.46 $11.2 Million - $12.8 Million
186,241 Added 2.92%
6,561,003 $424 Million
Q4 2020

Feb 10, 2021

SELL
$56.65 - $64.55 $72.3 Million - $82.4 Million
-1,277,117 Reduced 16.69%
6,374,762 $371 Million
Q3 2020

Nov 13, 2020

SELL
$62.1 - $78.08 $77.6 Million - $97.6 Million
-1,249,368 Reduced 14.04%
7,651,879 $484 Million
Q2 2020

Aug 13, 2020

SELL
$72.34 - $84.0 $263 Million - $305 Million
-3,629,962 Reduced 28.97%
8,901,247 $685 Million
Q1 2020

May 14, 2020

SELL
$62.63 - $80.22 $278 Million - $356 Million
-4,431,735 Reduced 26.13%
12,531,209 $937 Million
Q4 2019

Feb 13, 2020

BUY
$61.62 - $67.78 $137 Million - $151 Million
2,228,686 Added 15.13%
16,962,944 $1.1 Billion
Q3 2019

Nov 13, 2019

BUY
$62.51 - $69.0 $125 Million - $138 Million
1,994,010 Added 15.65%
14,734,258 $934 Million
Q2 2019

Aug 12, 2019

BUY
$61.87 - $69.38 $286 Million - $321 Million
4,620,000 Added 56.89%
12,740,248 $861 Million
Q1 2019

May 14, 2019

BUY
$62.53 - $70.05 $171 Million - $191 Million
2,730,700 Added 50.67%
8,120,248 $528 Million
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $326 Million - $426 Million
5,389,548 New
5,389,548 $337 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.